Great news found on the IHUB board,
Fletch


TTTav66 Friday, 08/21/20 07:26:59 PM
Re: None 0
Post # of 266662

Australian specialist pharmaceutical wholesaler and distributor, HL Pharma, announced this past week:
Quote:
Anavex Life Sciences and HL Pharma
HL Pharma is pleased to announce we are working with Anavex Life Sciences Corporation to facilitate the ongoing supply of medication to patients post clinical trial completions for Rett Syndrome and the treatment of Alzheimer’s Disease.

Supplies are being made under The TGA Special Access Scheme regulations.

https://www.anavex.com/anavex-life-sciences-r...-patients/

https://www.9news.com.au/national/rett-syndro...80b3a4ff24
Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to ageing populations (Parkinson’s Disease and Alzheimer’s Disease)

https://hlpharma.com.au/anavex-life-sciences-and-hl-pharma/

https://investorshub.advfn.com/boards/read_ms...=157802386